Inhibrx (INBX) Short Interest Ratio & Short Volume → get a piece of the profit from this land (From True Market Insiders) (Ad) Free INBX Stock Alerts $34.70 +0.21 (+0.61%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Inhibrx Short Interest DataCurrent Short Volume2,190,000 sharesPrevious Short Volume2,200,000 sharesChange Vs. Previous Month-0.45%Dollar Volume Sold Short$74.55 millionShort Interest Ratio / Days to Cover4.7Last Record DateApril 30, 2024Outstanding Shares52,400,000 sharesPercentage of Shares Shorted4.18%Today's Trading Volume967,426 sharesAverage Trading Volume493,023 sharesToday's Volume Vs. Average196% Short Selling Inhibrx ? Sign up to receive the latest short interest report for Inhibrx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINBX Short Interest Over TimeINBX Days to Cover Over TimeINBX Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Inhibrx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,190,000 shares $74.55 million -0.5%N/A4.7 $34.04 4/15/20242,200,000 shares $76.43 million +2.3%6.2%3.2 $34.74 3/31/20242,150,000 shares $75.16 million +34.4%6.0%3 $34.96 3/15/20241,600,000 shares $56 million -18.0%4.5%2.1 $35.00 2/29/20241,950,000 shares $71.43 million -7.1%5.5%2.6 $36.63 2/15/20242,100,000 shares $79.78 million -12.5%5.9%3 $37.99 Get the Latest News and Ratings for INBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,400,000 shares $92.47 million -41.3%6.7%3.4 $38.53 1/15/20244,090,000 shares $142.74 million +20.3%11.5%6.1 $34.90 12/31/20233,400,000 shares $129.20 million -6.1%9.6%7.4 $38.00 12/15/20233,620,000 shares $101.83 million -30.1%10.2%8.9 $28.13 11/30/20235,180,000 shares $107.59 million -2.1%15.0%12 $20.77 11/15/20235,290,000 shares $107.23 million +5.4%15.3%12 $20.27 10/31/20235,020,000 shares $77.66 million +1.0%15.0%11.2 $15.47 10/15/20234,970,000 shares $87.97 million -7.1%14.9%10.5 $17.70 9/30/20235,350,000 shares $98.17 million +11.2%16.0%11.9 $18.35 9/15/20234,810,000 shares $100.58 million -5.5%14.4%11.3 $20.91 8/31/20235,090,000 shares $108.93 million -12.8%15.3%12.8 $21.40 8/15/20235,840,000 shares $99.69 million +1.7%17.5%15.7 $17.07 7/31/20235,740,000 shares $115.09 million +0.9%18.0%16.4 $20.05 7/15/20235,690,000 shares $138.32 million -1.4%17.9%17 $24.31 6/30/20235,770,000 shares $149.79 million -4.0%18.2%16 $25.96 6/15/20236,010,000 shares $167.20 million +1.0%20.4%15.8 $27.82 5/31/20235,950,000 shares $140.78 million +3.3%20.2%15.4 $23.66 5/15/20235,760,000 shares $144.86 million +0.4%19.6%13.8 $25.15 4/30/20235,740,000 shares $120.54 million -2.1%19.5%14.1 $21.00 4/15/20235,860,000 shares $106.95 million -0.3%19.9%15.1 $18.25 3/31/20235,880,000 shares $110.96 million -3.0%20.0%14.5 $18.87 3/15/20236,060,000 shares $136.71 million +7.8%20.6%14.4 $22.56 2/28/20235,620,000 shares $135.22 million +8.5%19.1%12.9 $24.06 2/15/20235,180,000 shares $120.90 million -1.7%17.6%12.3 $23.34 1/31/20235,270,000 shares $131.75 million -3.0%19.1%11.7 $25.00 1/15/20235,430,000 shares $128.47 million +26.3%18.1%11.3 $23.66 12/30/20224,300,000 shares $105.95 million +8.6%14.4%8.5 $24.64 12/15/20223,960,000 shares $110.96 million -10.8%13.2%5.4 $28.02 11/30/20224,440,000 shares $133.11 million -1.1%15.7%5.7 $29.98 11/15/20224,490,000 shares $146.82 million -2.8%15.9%5.8 $32.70 10/31/20224,620,000 shares $148.67 million +16.7%18.0%6.2 $32.18 10/15/20223,960,000 shares $118.21 million -4.1%15.5%5.5 $29.85 9/30/20224,130,000 shares $74.13 million +25.5%16.2%5.9 $17.95 9/15/20223,290,000 shares $48.66 million +0.6%12.9%6.9 $14.79The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. INBX Short Interest - Frequently Asked Questions What is Inhibrx's current short interest? Short interest is the volume of Inhibrx shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 2,190,000 shares of INBX short. Learn More on Inhibrx's current short interest. What is a good short interest ratio for Inhibrx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INBX shares currently have a short interest ratio of 5.0. Learn More on Inhibrx's short interest ratio. Which institutional investors are shorting Inhibrx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Inhibrx: Equitec Proprietary Markets LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Inhibrx's short interest increasing or decreasing? Inhibrx saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 2,190,000 shares, a decline of 0.5% from the previous total of 2,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Inhibrx's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Inhibrx: Fusion Pharmaceuticals Inc. (4.64%), Ginkgo Bioworks Holdings, Inc. (20.84%), Novavax, Inc. (32.00%), Sana Biotechnology, Inc. (20.85%), Beam Therapeutics Inc. (17.03%), Neumora Therapeutics, Inc. (12.27%), ADMA Biologics, Inc. (3.82%), Tarsus Pharmaceuticals, Inc. (20.28%), Kymera Therapeutics, Inc. (16.15%), Vir Biotechnology, Inc. (6.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Inhibrx stock? Short selling INBX is an investing strategy that aims to generate trading profit from Inhibrx as its price is falling. INBX shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inhibrx? A short squeeze for Inhibrx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INBX, which in turn drives the price of the stock up even further. How often is Inhibrx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: FUSN Short Squeeze DNA Short Squeeze NVAX Short Squeeze SANA Short Squeeze BEAM Short Squeeze NMRA Short Squeeze ADMA Short Squeeze TARS Short Squeeze KYMR Short Squeeze VIR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INBX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersNext President (Not Trump. Not Biden.)The Freeport SocietyA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets